Peter Smith‐Jones

10.4k citations

86 papers · 7.3k indexed · 2 hit papers · h-index 41

Impact in

Radiology, Nuclear Medicine and Imaging top 0.2%
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
Cancer Research top 1%
- MicroRNA in disease regulation

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 53
- Radiopharmaceutical Chemistry and Applications 44
- Monoclonal and Polyclonal Antibodies Research 21
- Medical Imaging Techniques and Applications 7
Neurology 16
- Neuroblastoma Research and Treatments 14

Co-authors: Steven M. Larson (33 shared papers)Neil H. Bander (10 shared papers)Michael W. Graner (2 shared papers)Tyson Smyth (2 shared papers)Thomas J. Anchordoquy (2 shared papers)Charles L. Sawyers (2 shared papers)John Wongvipat (2 shared papers)Howard I. Scher (7 shared papers)
Journals: Journal of Nuclear Medicine (8 papers)Nuclear Medicine and Biology (5 papers)European Journal of Nuclear Medicine and Molecular Imaging (4 papers)PLoS ONE (3 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Switzerland Austria

In The Last Decade

Peter Smith‐Jones

86 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes 2014 · 600 citations

Peers

Countries citing papers authored by Peter Smith‐Jones

Since Specialization

Citations

This map shows the geographic impact of Peter Smith‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Smith‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Smith‐Jones more than expected).

Fields of papers citing papers by Peter Smith‐Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Smith‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Smith‐Jones. The network helps show where Peter Smith‐Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Smith‐Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Smith‐Jones Line = papers co-authored together Peter Smith‐Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer Science ·Chris Tran, Samedy Ouk, Nicola J. Clegg, Yu Chen, Philip A. Watson, Vivek Arora, John Wongvipat, Peter Smith‐Jones, Dongwon Yoo, Andrew Kwon, Teresa Wasielewska, Derek S. Welsbie, Charlie Degui Chen, Celestia S. Higano, Tomasz M. Beer, David T. Hung, Howard I. Scher, Michael E. Jung, Charles L. Sawyers Hit paper breakdown →	2009	1689
2	Biodistribution and delivery efficiency of unmodified tumor-derived exosomes Journal of Controlled Release ·Tyson Smyth, Max Kullberg, Noeen Malik, Peter Smith‐Jones, Michael W. Graner, Thomas J. Anchordoquy Hit paper breakdown →	2014	600
3	Surface Functionalization of Exosomes Using Click Chemistry Bioconjugate Chemistry ·Tyson Smyth, Krastina Petrova, Nicole M. Payton, Indushekhar Persaud, Jasmina S. Redzic, Michael W. Graner, Peter Smith‐Jones, Thomas J. Anchordoquy	2014	407
4	⁸⁹Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo Journal of Nuclear Medicine ·Jason P. Holland, Vadim Divilov, Neil H. Bander, Peter Smith‐Jones, Steven M. Larson, Jason S. Lewis	2010	338
5	Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen Proceedings of the National Academy of Sciences ·Michael J. Evans, Peter Smith‐Jones, John Wongvipat, Vincent Navarro, Sae Kim, Neil H. Bander, Steven M. Larson, Charles L. Sawyers	2011	247
6	In vivo biodistribution and accumulation of 89Zr in mice Nuclear Medicine and Biology ·Diane S. Abou, Thomas W. Ku, Peter Smith‐Jones	2011	234
7	Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors Nature Biotechnology ·Peter Smith‐Jones, David B. Solit, Timothy Akhurst, Farzana Afroze, Neal Rosen, Steven M. Larson	2004	228
8	Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen The Journal of Urology ·Neil H. Bander, Edouard J. Trabulsi, Lale Kostakoğlu, Daniel Yao, Shankar Vallabhajosula, Peter Smith‐Jones, Maureen A. Joyce, Matthew I. Milowsky, David M. Nanus, Stanley J. Goldsmith	2003	198
9	Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma Journal of Neuro-Oncology ·Kim Kramer, Brian H. Kushner, Shakeel Modak, Neeta Pandit‐Taskar, Peter Smith‐Jones, Pat Zanzonico, John L. Humm, Hong Xu, Suzanne L. Wolden, Mark M. Souweidane, Steven M. Larson, Nai‐Kong V. Cheung	2009	179
10	In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. PubMed ·Peter Smith‐Jones, Shankar Vallabahajosula, Stanley J. Goldsmith, Vincent Navarro, Catherine J. Hunter, Diego Bastidas, Neil H. Bander	2000	172
11	Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models International Journal of Radiation OncologyBiologyPhysics ·Joseph A. O’Donoghue, Pat Zanzonico, Andrei Pugachev, Bixiu Wen, Peter Smith‐Jones, Shangde Cai, Eva Burnazi, Ronald D. Finn, Paul Burgman, Shutian Ruan, Jason S. Lewis, Michael J. Welch, Charlotte Ling, John L. Humm	2005	148
12	Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. PubMed ·Peter Smith‐Jones, Shankar Vallabhajosula, Vincent Navarro, Diego Bastidas, Stanley J. Goldsmith, Neil H. Bander	2003	142
13	Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET. PubMed ·Peter Smith‐Jones, David B. Solit, Farzana Afroze, Neal Rosen, Steven M. Larson	2006	127
14	The somatostatin receptor-targeted radiotherapeutic [ 90 Y-DOTA- d Phe 1 ,Tyr 3 ]octreotide ( 90 Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours European Journal of Nuclear Medicine and Molecular Imaging ·Barbara Stolz, Gisbert Weckbecker, Peter Smith‐Jones, Rainer Albert, Friedrich Raulf, Christian Bruns	1998	109
15	Clinical Use of Monoclonal Antibody HuJ591 Therapy: Targeting Prostate Specific Membrane Antigen The Journal of Urology ·David M. Nanus, Matthew I. Milowsky, Lale Kostakoğlu, Peter Smith‐Jones, Shankar Vallabahajosula, Stanley J. Goldsmith, Neil H. Bander	2003	108
16	Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. PubMed ·Peter Smith‐Jones, Barbara Stolz, Christian Bruns, Rainer Albert, H.W. Reist, R Fridrich, Helmut R. Mäcke	1994	101
17	Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer Clinical Cancer Research ·Michael J. Morris, Chaitanya Divgi, Neeta Pandit‐Taskar, Maria Batraki, Nyasha Warren, Angelo Nacca, Peter Smith‐Jones, Lawrence H. Schwartz, William K. Kelly, Susan F. Slovin, David B. Solit, Jennifer L. Halpern, A. Delacruz, Tracy Curley, Ronald D. Finn, Joseph A. O’Donoghue, Philip O. Livingston, Steven M. Larson, Howard I. Scher	2005	93
18	Pharmacokinetic Assessment of the Uptake of 16β-¹⁸F-Fluoro-5α-Dihydrotestosterone (FDHT) in Prostate Tumors as Measured by PET Journal of Nuclear Medicine ·Bradley J. Beattie, Peter Smith‐Jones, Yuliya Jhanwar, Heiko Schöder, C. Ross Schmidtlein, Michael J. Morris, Pat Zanzonico, Olivia Squire, Gustavo Souza Portes Meirelles, Ron Finn, Mohammad Namavari, Shangde Cai, Howard I. Scher, Steven M. Larson, John L. Humm	2010	89
19	¹²⁴I-huA33 Antibody PET of Colorectal Cancer Journal of Nuclear Medicine ·Jorge A. Carrasquillo, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, John L. Humm, Pat Zanzonico, Peter Smith‐Jones, Chaitanya Divgi, Daniel A. Pryma, Shutian Ruan, Nancy E. Kemeny, Yuman Fong, Douglas W. Wong, Jaspreet Singh Jaggi, David A. Scheinberg, Mithat Gönen, Katherine S. Panageas, Gerd Ritter, Achim A. Jungbluth, Lloyd J. Old, Steven M. Larson	2011	72
20	Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with ²²⁵Ac for α-Particle Radioimmunotherapy of Cancer Journal of Nuclear Medicine ·William F. Maguire, Michael R. McDevitt, Peter Smith‐Jones, David A. Scheinberg	2014	72

About Peter Smith‐Jones

Peter Smith‐Jones is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 86 papers that have together received 7.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (44 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Neuroendocrine Tumor Research Advances (20 papers), Prostate Cancer Treatment and Research (14 papers), Neuroblastoma Research and Treatments (14 papers), Lung Cancer Research Studies (11 papers), HER2/EGFR in Cancer Research (8 papers) and Medical Imaging Techniques and Applications (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.1k citations), Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.9k citations), Oncology (1.9k citations) and Molecular Biology (2.5k citations). Peter Smith‐Jones has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Steven M. Larson, Neil H. Bander, Michael W. Graner, Tyson Smyth, Thomas J. Anchordoquy, Charles L. Sawyers, John Wongvipat, Howard I. Scher, Max Kullberg and Noeen Malik. Their work appears in journals such as Journal of Nuclear Medicine, Nuclear Medicine and Biology, European Journal of Nuclear Medicine and Molecular Imaging, PLoS ONE and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact